HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Joseph Géczy Selected Research

Molsidomine (SIN 10)

7/2006Tolerability to 1-year treatment with once-daily molsidomine in patients with stable angina.
1/2006Efficacy and safety of once- and twice-daily formulations of molsidomine in patients with stable angina pectoris: double-blind and open-label studies.
6/2005Long-term treatment with the NO-donor molsidomine reduces circulating ICAM-1 levels in patients with stable angina.
1/2005Efficacy and safety of molsidomine once-a-day in patients with stable angina pectoris.
7/2003A pilot double-blind randomized placebo-controlled study of molsidomine 16 mg once-a-day in patients suffering from stable angina pectoris: correlation between efficacy and over time plasma concentrations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Joseph Géczy Research Topics

Disease

5Stable Angina
07/2006 - 07/2003
2Headache (Headaches)
07/2006 - 01/2005
1Atherosclerosis
06/2005
1Hypotension (Low Blood Pressure)
01/2005
1Ischemia
07/2003
1Acidosis
06/2002

Drug/Important Bio-Agent (IBA)

5Molsidomine (SIN 10)IBA
07/2006 - 07/2003
2Pharmaceutical PreparationsIBA
07/2006 - 01/2005
1CalciumIBA
07/2006
1Nitric Oxide DonorsIBA
01/2006
1Nitric Oxide (Nitrogen Monoxide)FDA Link
06/2005
1Biomarkers (Surrogate Marker)IBA
06/2005
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
06/2005
1ethylisopropylamiloride (EIPA)IBA
06/2002

Therapy/Procedure

1Therapeutics
07/2006